NCT03950609 2026-03-19
Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
M.D. Anderson Cancer Center
Grupo Espanol de Tumores Neuroendocrinos
Exelixis
SAPU NANO (US) LLC
RayzeBio, Inc.